Cerecor Inc. Uncategorized Contracts & Agreements

19 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Avalo Therapeutics, Inc
Cerecor Inc.
Pharmaceuticals
2024
Avalo Therapeutics, Inc. Fo
Cerecor Inc.
Pharmaceuticals
DE
2024
Description of Registered Securities
Cerecor Inc.
Pharmaceuticals
2022
Letter Agreement, dated February
Cerecor Inc.
Pharmaceuticals
2022
Letter Agreement, dated February 18, 2022, by and between Avalo Therapeutics, Inc. and Garry Neil
Cerecor Inc.
Pharmaceuticals
2022
Amendment No
Cerecor Inc.
Pharmaceuticals
2021
Controlled Equity Offering
Cerecor Inc.
Pharmaceuticals
NY
2021
Offer Letter, dated February 19, 2020, from Cerecor Inc. to H. Jeffrey Wilkins, M.D
Cerecor Inc.
Pharmaceuticals
2021
Description of Registered Securities
Cerecor Inc.
Pharmaceuticals
2021
Amendment No. 6 to Sponsored Research Agreement, dated as of
Cerecor Inc.
Pharmaceuticals
2020
Letter Agreement, dated April 23, 2020, by and between Cerecor Inc. and Christopher Sullivan
Cerecor Inc.
Pharmaceuticals
2020
Description of Registered Securities
Cerecor Inc.
Pharmaceuticals
2020
Backstop Agreement, dated December 5, 2019, by and between Cerecor Inc. and Armistice Capital Master Fund Ltd
Cerecor Inc.
Pharmaceuticals
DE
2019
Form of Contingent Value Rights Agreement by and between Cerecor Inc. and Rights Agent
Cerecor Inc.
Pharmaceuticals
DE
2019
[Cerecor, Inc. Letterhead]
Cerecor Inc.
Pharmaceuticals
2016
Form of UPO
Cerecor Inc.
Pharmaceuticals
NY
2015
SPECIMEN UNIT CERTIFICATE
Cerecor Inc.
Pharmaceuticals
2015
CERECOR INC.
Cerecor Inc.
Pharmaceuticals
2015
Cerecor Inc. 75 Rockefeller Plaza, 29thFloor New York, NY 10019
Cerecor Inc.
Pharmaceuticals
DE
2015